LIQUID-BIOPSY BASED NOVEL MRNA GENOMIC TEST FOR EARLY DETECTION, PROGNOSIS AND MONITORING OF PROSTATE CANCER: A MULTICENTER STUDY

被引:0
|
作者
Hashimoto, Yutaka
Verma, Shiv
Deng, Guoren
Chauhan, Dharam P.
Nair, Sujit
Chakravarty, Dimple
Yoshino, Hirofumi
Arima, Junya
Tatarano, Shuichi
Liu, Yutong
Hatano, Koji
Shivakumar, Yogesh
Ghosh, Mithua
Krishnappa, Raghunath S.
Chandran, Chitra
Ragavan, Narasimhan
Enokida, Hideki
Nonomura, Norio
Balaji, K. C.
Rawal, Sudhir K.
Tewari, Ashutosh K.
Dahiya, Rajvir
Gupta, Sanjay
机构
来源
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP41-05
引用
收藏
页码:E674 / E674
页数:1
相关论文
共 50 条
  • [1] A novel blood-based mRNA genomic test for screening, early detection, prognosis, and monitoring of prostate cancer: A multicenter study.
    Hashimoto, Yutaka
    Verma, Shiv
    Deng, Guoren
    Chauhan, Dharam P.
    Nair, Sujit
    Yoshino, Hirofumi
    Arima, Junya
    Liu, Yutong
    Hatano, Koji
    Shivakumar, Yogesh
    Krishnappa, Raghunath S.
    Chandran, Chitra
    Ragavan, Narasimhan
    Enokida, Hideki
    Nonomura, Norio
    Balaji, K. C.
    Rawal, Sudhir K.
    Tewari, Ashutosh K.
    Dahiya, Rajvir
    Gupta, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 271 - 271
  • [2] Blood based novel mRNA genomic test, for screening, early detection, prognosis and monitoring of prostate cancer using a multi-center study
    Hashimoto, Yutaka
    Verma, Shiv
    Deng, Guoren
    Chauhan, Dharam P.
    Nair, Sujit
    Chakravarty, Dimple
    Yoshino, Hirofumi
    Arima, Junya
    Tatarano, Shuichi
    Liu, Yutong
    Hatano, Koji
    Shivakumar, Yogesh
    Ghosh, Mithua
    Raghunath, Krishnappa
    Chandran, Chitra
    Ragavan, Narasimhan
    Enokida, Hideki
    Nonomura, Norio
    Balaji, K. C.
    Rawal, Sudhir
    Tewari, Ashutosh
    Dahiya, Rajvir
    Gupta, Sanjay
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Early detection, clinicopathological subtyping and prognosis prediction for patients with endometrial cancer using fragmentoimcs-based liquid-biopsy assay
    Rao, Qunxian
    Zhou, Hui
    Weng, Wanying
    He, Yiru
    Tang, Wanxiangfu
    Chen, Xiaoxi
    Wu, Xuxiaochen
    Bao, Hua
    Lin, Zhongqiu
    Zhang, Bingzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Liquid biopsy for detection of genomic instability in prostate cancer
    Pos, O.
    Budis, J.
    Radvansky, J.
    Harsaniova, M.
    Strieskova, L.
    Duri, F.
    Bohmer, M.
    Gazdarica, J.
    Gazdaricova, I.
    Turna, J.
    Szemes, T.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 460 - 460
  • [5] Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer
    Jong-chan Lee
    Sung Won Kang
    Eun-Jin Sim
    Jin-Sik Bae
    Seong-mo Koo
    Mun-sub Byoun
    Serin Kwon
    Seoi Hong
    Yunji Kim
    Yuna Youn
    Kwangrok Jung
    Jaihwan Kim
    Hyoung Hwa Jeong
    Jihie Kim
    Jin-Hyeok Hwang
    BMC Cancer, 25 (1)
  • [6] Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
    Zhou, Hui
    Zhu, Liyong
    Song, Jun
    Wang, Guohui
    Li, Pengzhou
    Li, Weizheng
    Luo, Ping
    Sun, Xulong
    Wu, Jin
    Liu, Yunze
    Zhu, Shaihong
    Zhang, Yi
    MOLECULAR CANCER, 2022, 21 (01)
  • [7] Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
    Hui Zhou
    Liyong Zhu
    Jun Song
    Guohui Wang
    Pengzhou Li
    Weizheng Li
    Ping Luo
    Xulong Sun
    Jin Wu
    Yunze Liu
    Shaihong Zhu
    Yi Zhang
    Molecular Cancer, 21
  • [8] Advances in liquid biopsy approaches for early detection and monitoring of cancer
    Babayan, Anna
    Pantel, Klaus
    GENOME MEDICINE, 2018, 10
  • [9] Early detection and monitoring of cancer in liquid biopsy: advances and challenges
    Xue, Vivian Weiwen
    Wong, Cesar Sze Chuen
    Cho, William Chi Shing
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (04) : 273 - 276
  • [10] Advances in liquid biopsy approaches for early detection and monitoring of cancer
    Anna Babayan
    Klaus Pantel
    Genome Medicine, 10